These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17336523)

  • 1. The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase.
    Whitlow M; Adler M; Davey D; Huang Q; Koovakkat S; Parkinson JF; Pham E; Polokoff M; Xu W; Yuan S; Phillips G
    Bioorg Med Chem Lett; 2007 May; 17(9):2505-8. PubMed ID: 17336523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
    Wei RG; Adler M; Davey D; Ho E; Mohan R; Polokoff M; Tseng JL; Whitlow M; Xu W; Yuan S; Phillips G
    Bioorg Med Chem Lett; 2007 May; 17(9):2499-504. PubMed ID: 17368901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
    López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
    Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors.
    Patman J; Bhardwaj N; Ramnauth J; Annedi SC; Renton P; Maddaford SP; Rakhit S; Andrews JS
    Bioorg Med Chem Lett; 2007 May; 17(9):2540-4. PubMed ID: 17317165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
    Davey DD; Adler M; Arnaiz D; Eagen K; Erickson S; Guilford W; Kenrick M; Morrissey MM; Ohlmeyer M; Pan G; Paradkar VM; Parkinson J; Polokoff M; Saionz K; Santos C; Subramanyam B; Vergona R; Wei RG; Whitlow M; Ye B; Zhao ZS; Devlin JJ; Phillips G
    J Med Chem; 2007 Mar; 50(6):1146-57. PubMed ID: 17315988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
    Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
    Grädler U; Fuchss T; Ulrich WR; Boer R; Strub A; Hesslinger C; Anézo C; Diederichs K; Zaliani A
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4228-32. PubMed ID: 21684157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
    Cheshire DR; Åberg A; Andersson GM; Andrews G; Beaton HG; Birkinshaw TN; Boughton-Smith N; Connolly S; Cook TR; Cooper A; Cooper SL; Cox D; Dixon J; Gensmantel N; Hamley PJ; Harrison R; Hartopp P; Käck H; Leeson PD; Luker T; Mete A; Millichip I; Nicholls DJ; Pimm AD; St-Gallay SA; Wallace AV
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2468-71. PubMed ID: 21398123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
    Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
    Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering new inhibitors of bacterial glucosamine-6P synthase (GlmS) by docking simulations.
    Floquet N; Richez C; Durand P; Maigret B; Badet B; Badet-Denisot MA
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1966-70. PubMed ID: 17291748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
    J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally constrained NO synthase inhibitors: rigid analogs of L-N-iminoethylornithine.
    Eustache J; Grob A; Lam C; Sellier O; Schulz G
    Bioorg Med Chem Lett; 1998 Nov; 8(21):2961-6. PubMed ID: 9873655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of iNOS inhibitors using InteraX.
    Mallinder PR; Wallace AV; Allenby G
    J Biomol Screen; 2009 Mar; 14(3):263-72. PubMed ID: 19211775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma.
    Lee YZ; Yang CW; Kang IJ; Wu SH; Chao YS; Chern JH; Lee SJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5676-9. PubMed ID: 18809325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.
    López-Cara LC; Carrión MD; Entrena A; Gallo MA; Espinosa A; López A; Escames G; Acuña-Castroviejo D; Camacho ME
    Eur J Med Chem; 2012 Apr; 50():129-39. PubMed ID: 22336385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
    Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclo(dehydrohistidyl-l-tryptophyl) inhibits nitric oxide production by preventing the dimerization of inducible nitric oxide synthase.
    Sohn MJ; Hur GM; Byun HS; Kim WG
    Biochem Pharmacol; 2008 Feb; 75(4):923-30. PubMed ID: 18061143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.